Molecular Devices, a subsidiary of Danaher Corporation, is a leading company in the life sciences, diagnostics, and biotechnology sectors. Committed to innovation and tangible impact, Molecular Devices develops automated and AI-enabled technologies that empower researchers in academia, biotech, pharma, and government to tackle complex scientific questions. The company fosters a culture of collaboration, authenticity, and innovation, aiming to enhance lives globally through groundbreaking scientific discoveries. With a focus on continuous improvement through the Danaher Business System, Molecular Devices is dedicated to accelerating the development of safer and more effective therapeutics, ultimately shaping a healthier future for all.